A Dublin court recently approved a settlement of nearly €1 million for an 11-year-old girl who suffered life-shortening complications after a spinal surgery at Temple Street Children's University Hospital involved an unapproved metallic spring. The case, widely reported across Irish media as Court approves €1m for girl operated on at Temple Street - RTE ie, reveals a frightening gap between clinical innovation and engineering governance. For those of us who build systems that directly affect human life-whether medical devices, autopilots, or critical infrastructure-this story is a stark reminder that "unapproved modifications" aren't just a software concern. They can cost lives. And this €1m settlement is only the visible tip of an iceberg of technical debt.
This article doesn't recount the headline alone. Instead, we will dissect the engineering failures that allowed a non‑CE‑marked spring to be inserted into a child's spine, drawing direct parallels to software development, regulatory compliance. And the cultural gaps that enable such deviations. Every paragraph advances a single thesis: that engineering teams in any high‑stakes domain must treat unapproved change as existential risks, not as shortcuts to "get the job done. "
The Medical Device Engineering Failure at Temple Street - A Case Study in Uncontrolled Change
During a spinal fusion procedure on the then‑10‑year‑old girl, surgeons used a spring that hadn't been approved for implantation. The device, originally intended for a different purpose, was modified off‑label without proper engineering design control. The result: the spring would have protruded from her shoulders or back. And her life expectancy was reduced. The €1m settlement covers future care, pain and suffering, and loss of potential earnings - but it cannot reverse the physical harm.
From an engineering perspective, this is a textbook failure of the design history file (DHF). In regulated medical device development, every component must be traced from specification through verification and validation. An unapproved spring means no risk analysis, no biocompatibility testing, no fatigue testing under physiological loads. The hospital's internal investigation (likely following ISO 13485 complaint handling procedures) uncovered the unauthorized device. The takeaway for engineers: never bypass documented approval workflows, even under time pressure.
Software-Quality Parallels: How Unapproved Code Changes Echo Through Production
Software engineers might read this and recall a time a "hotfix" was deployed without code review, only to crash a production database. The analogy is uncomfortably close. In the Temple Street case, the spring was used without a formal design change order - akin to merging untested code into a production branch without a pull request or CI pipeline. The consequences, amplified by the physical world, were irreversible,
In safety‑critical software (eg., medical device firmware, avionics, autonomous driving), change management is governed by standards such as FDA Design Controls and IEC 62304. These standards require that every change be analyzed for impact on safety, retested. And documented. When a team skips that step - whether because of a "minor" adjustment to a spring or a "trivial" patch to an embedded sensor - they're effectively rolling dice with human life. The €1m settlement is the cost of that gamble.
The Approvals Pipeline: Lessons from FDA 510(k) and ISO 13485 Frameworks
The spring used at Temple Street wasn't the one that had passed hospital procurement and regulatory review. In the United States, medical devices must generally go through either a premarket approval (PMA) or a 510(k) clearance if they are substantially equivalent to an already legally marketed device. Off‑label use of a non‑equivalent component violates the very basis of that equivalence. The US FDA's 510(k) process is built on the assumption that the device manufacturer has design control over every part.
In Ireland, the Health Products Regulatory Authority (HPRA) enforces the EU Medical Device Regulation (MDR) and requires CE marking for all implants. An unapproved spring has no CE mark; it was never subjected to the required conformity assessment. This case demonstrates that regulatory pipelines are only as strong as the enforcement of internal approvals. Any engineer working in a regulated environment - even outside medtech, such as automotive or industrial control - must treat the approval chain as non‑negotiable. When someone says "this is just a minor part, we can skip the approval," they're increasing risk exponentially.
Metrics That Matter: Quantifying Patient Harm vs. Technical Debt
The settlement amount - €1m - provides a concrete number. But the real cost is the girl's shortened life expectancy. In software engineering, we quantify technical debt For future maintenance effort, bugs, and downtime. But when the debt is physical, the metrics are different: reduced quality of life, years of life lost. And litigation costs. The €1m figure isn't just compensation; it is the economic equivalent of the engineering debt incurred by using an unapproved spring.
Consider a parallel in embedded systems: a medical infusion pump was deployed with a third‑party pump motor that hadn't been validated for continuous duty. After a year, the motor failed, causing a delayed infusion that harmed a patient. The recall cost $2, and 5MIn both cases, the root cause was a deviation from the approved bill of materials. Engineers who track technical debt should include the cost of potential recalls, lawsuits, and reputational damage. That makes the debt far larger than any short‑term savings from skipping approvals.
Why 'It Worked in the Demo' isn't a Safety Case
Surgeons often rely on "it worked in the lab" or "it worked on a cadaver" as justification for off‑label use. In software, we hear "it passed unit tests on my machine. " Neither is sufficient for a safety‑critical system. The spring may have functioned under static loading in a benchtop test. But it was never subjected to dynamic fatigue testing in a living spine, with growth‑related forces over years. The failure mode - protrusion - would have been discovered if proper verification protocols had been followed.
Engineers must reject any test that doesn't replicate the full stress environment. For medical devices, that means animal studies, finite element analysis. And long‑term implant retrieval studies. For software, it means integration tests, stress tests, and canary deployments. A demo isn't a safety case; a green tick on a CI pipeline isn't a safety case. Both require traceability back to a hazard analysis document (e g, and, an FMEA)The Temple Street case teaches us that the phrase "it works" is the most dangerous phrase in engineering.
The Psychological Safety of Blame-Free Incident Reporting
Notably, the court‑approved settlement was preceded by an internal hospital investigation that identified the unapproved spring. That investigation was only possible because staff felt safe to report what had happened. In engineering organizations, the same principle applies: a blame‑free post‑mortem culture (like those pioneered by postmortem practices in companies like Google and Etsy) encourages reporting of near‑misses and deviations.
If the hospital had a punitive culture, the use of an unapproved spring might have been buried, leading to more cases and larger eventual harm. Health‑care organizations are increasingly adopting "just culture" models from aviation and nuclear power. Software teams should do the same: when an engineer bypasses code review, the response should be a structured investigation into why the process was bypassed, not a blaming of the individual. The settlement could have been prevented if the first instance of using an unapproved component had been caught via a reporting system. Psychological safety isn't soft; it's a risk mitigation tool.
Regulatory Technology (RegTech) for Medical Devices - AI and Blockchain Solutions
What if we could automate the approval chain? Emerging regulatory technology (RegTech) uses blockchain to create immutable logs of device components from manufacturer to implantation. A smart contract could verify that every part in a surgical kit has a valid CE mark or FDA clearance before the kit leaves the warehouse. Similarly, AI‑powered surgical checklists could flag off‑label components when scanned with a barcode reader at the operating table.
These solutions aren't science fiction. Companies like Medicalchain are exploring blockchain for medical records. And the same architecture can be applied to implant traceability. In software, we already use dependency scanning (e g., Snyk, GitHub Dependabot) to catch unapproved third‑party libraries. Imagine a system that refuses to compile a surgical plan if any component isn't in the approved bill of materials. The technological capability exists; the gap is adoption and integration into clinical workflows.
What This Case Means for Engineers Building Safety-Critical Systems
For engineers reading this - whether you work on surgical robots, flight control software. Or nuclear reactor management - the Temple Street settlement offers three concrete takeaways:
- Demand traceability. Every component in your system must have a documented origin, approval status. And risk assessment. If you can't prove it, it isn't safe,
- Question deviations When someone asks to use an alternative part or a different library, treat it as a change request requiring full impact analysis. "It's just a smaller spring" is just as risky as "it's just a minor refactor. "
- Document assumptions. In design reviews, explicitly state why you chose a specific component. If that component later shows up in a different context (e. And g, a spring from a toy model used as a spine implant), the documentation can catch the mismatch.
The €1m settlement isn't just a news item; it's a case study for every engineering team that values human life over speed. Let it be a catalyst for reviewing your own change control processes.
Frequently Asked Questions (FAQ)
- What exactly was the "unapproved spring" used in the Temple Street surgery?
The spring was a metallic component intended for a different medical device and wasn't authorized for implantation in a child's spine. It was inserted during a spinal fusion without proper design control or regulatory clearance. - Why wasn't the spring approved before the surgery?
The hospital's investigation revealed that the device was used off‑label without following the standard procurement and approval pipeline required for implantable components. This bypassed risk assessments and biocompatibility testing. - How does this case relate to software engineering?
The core issue is an uncontrolled change in a safety‑critical system. In software, an unapproved code change can cause data loss or system failure; here, an unapproved physical component caused permanent harm to a patient. Both result from skipping established approval gates. - What are the potential consequences for Temple Street Children's Hospital?
The immediate consequence is the €1m settlement, but there may also be regulatory sanctions, increased insurance premiums, and mandatory changes to surgical protocols and procurement processes. The HPRA may conduct a full investigation. - Can technology prevent such incidents in the future,
YesAutomated inventory tracking with barcode scanning, blockchain‑based part authentication. And AI‑powered surgical checklists that verify each component against an approved list can reduce the risk of off‑label use. However, technology must be paired with a culture that enforces adherence to the approval pipeline.
Conclusion
The court's approval of €1m for the girl operated on at Temple Street is more than a legal settlement it's a teaching moment for every engineer who designs, builds. Or maintains systems that involve human safety. Unapproved changes, whether in a codebase or in an operating room, create unrecognized risk that can escalate into catastrophic failure. The best defense is a disciplined change control process, a culture that encourages reporting of deviations, and a willingness to invest in traceability tools.
As a call to action: if you're an engineering leader, schedule a review of your change management procedures this week. Ask your team for the last three times a part or package was used without full approval. Discuss how you would have caught the Temple‑Street‑style incident in your own domain. The cost of prevention is far less than €1m and, more importantly, far less than one child's shortened life.
What do you think?
Should hospitals (and tech companies) be legally required to publish anonymized reports of every unapproved component or code change, even if no harm occurred?
Is a €1m settlement enough to deter future deviations,? Or does it send a message that the fines of unsafe engineering are simply a cost of doing business?
How can we, as engineers, embed psychological safety into the approval process so that speaking up about a skipped step becomes the norm rather than the exception?
.
Need a Custom App Built?
Let's discuss your project and bring your ideas to life.
Contact Me Today →